Tigermed to Join Frontage Privatization and Divest Overseas Lab Business
Tigermed says it will participate in the privatization of Frontage Holdings and divest its overseas laboratory services business.
HANGZHOU, China, Nov. 10, 2026 // -- Hangzhou Tigermed Consulting Co., Ltd. (Stock Codes: 300347.SZ / 3347.HK, hereinafter referred to as "Tigermed"), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, today announ…